NCT00940771View on ClinicalTrials.gov

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 26, 2009

Primary Completion Date

October 16, 2013

Study Completion Date

November 23, 2016

Conditions
Pediatric HIVHIV Infections
Interventions
DRUG

Boosted Atazanavir

Boosted Atazanavir, once a day dose adjusted for child's weight for 6 months.

Trial Locations (1)

85016

Phoenix Children's Hospital, Phoenix

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Phoenix Children's Hospital

OTHER